Description
An imidazole nucleoside with immunosuppressive properties; inhibits T cell proliferation in response to various mitogenic stimuli by 10-100% (1-50 µg/mL); inhibits proliferation of stimulated T cells (IC50 = 5 µg/ml); inhibits guanine nucleotide formation in T cells, reducing GTP pools by 40-60% (5 µg/ml); inhibits replication of HCV RNA in vitro (IC50 = 100 µM); suppresses glomerulosclerosis, urinary albumin excretion, interstitial fibrotic lesions, and macrophage infiltration into glomeruli and the interstitium in a rat model of type 2 diabetes (5 or 10 mg/kg)
Formal name: 5-hydroxy-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide
Synonyms: NSC 289637
Molecular weight: 259.2
CAS: 50924-49-7
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Nucleotides/Nucleosides||Research Area|Cardiovascular System|Kidney & Renal Disease||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Immunology & Inflammation|Autoimmunity|Lupus||Research Area|Immunology & Inflammation|Autoimmunity|Rheumatoid Arthritis||Research Area|Immunology & Inflammation|Immunosuppressants||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Infectious Disease|Viral Diseases|Hepatitis